Showing results (61-70 of 191) with videos related to

Sort By:
Pageof 20
Innovations in Clinical Neuroscience|May 23, 2013
Novel therapeutic approach by nicotine in experimental model of multiple sclerosisFatemeh Naddafi, Mohsen Reza Haidari, Gholamreza Azizi, et al.
Iranian Journal of Allergy, Asthma, and Immunology|December 7, 2018
Modulation of Macrophage Polarization for Bone Tissue Engineering ApplicationsZahra Jamalpoor, Alireza Asgari, Mohammad Hossein Lashkari, et al.
International Journal of Dermatology|July 18, 2015
T-helper 22 cells as a new player in chronic inflammatory skin disordersAbbas Mirshafiey, Anita Simhag, Nadia M M El Rouby, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 28, 2004
Chemopreventive effect of M2000, a new anti-inflammatory agentAbbas Mirshafiey, Mohammad Reza Khorramizadeh, Farshid Saadat, et al.
Immunopharmacology and Immunotoxicology|April 6, 2018
Cardioprotective effect of β-d-mannuronic acid (M2000) as a novel NSAID on gene expression of oxLDL scavenger receptors in the experimental diabetic modelSeyed Shahabeddin Mortazavi-Jahromi, Shahab Alizadeh, Mohammad Hassan Javanbakht, et al.
Immunopharmacology and Immunotoxicology|October 12, 2002
Treatment of experimental nephrosis by culture filtrate of Cryptococcus neoformans var. gattii (CneF)Abbas Mirshafiey, Alireza Razavi, Farhad Mehrabian, et al.
Drug and Chemical Toxicology|September 20, 2019
Evaluation of the acute and 28-day sub-acute intravenous toxicity of α-l-guluronic acid (ALG; G2013) in miceAhmad Mahdian-Shakib, Mohammad Sadegh Hashemzadeh, Ali Anissian, et al.
Immunopharmacology and Immunotoxicology|July 27, 2021
The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditionsSafa Tahmasebi, Hassan Neishaboori, Davood Jafari, et al.
Pageof 20